Trial intelligence / Profile preview

STATIPLAT: Atorvastatin vs Rosuvastatin Loading Dose in PCI

NCT01526460Phase 2Completed

Sponsor
IRCCS Ospedale San Raffaele
Start
Aug 2011
Primary completion
Feb 2014
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of atorvastatin, rosuvastatin in coronary artery disease (CAD), angina pectoris, sponsored by IRCCS Ospedale San Raffaele. Started Aug 2011; status: completed.

02

Drugs

atorvastatinrosuvastatin
03

Conditions

coronary artery disease (CAD)angina pectoris

Beyond the preview

Go deeper on NCT01526460.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01526460.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call